Fig. 4From: Three-dimensional nuclear telomere architecture and differential expression of aurora kinase genes in chronic myeloid leukemia to measure cell transformationqPCR analysis of AURKA and AURKB mRNA expression in CML cells. Patients were divided in three distinct sub-groups (health donors, chronic phase and accelerated phase/blast phase). The graphs represent the mean ± SD of three independent experiments. The p values are indicated in the graphs; *p < 0.05, **p < 0.01; ANOVA test and Bonferroni post-testBack to article page